The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site.

All material subject to strictly enforced copyright laws. © 2020 Euromoney, a part of the Euromoney Institutional Investor PLC.

Standing up for your rights

Cash-strapped insurers are rushing to replenish funds through rights issues and secondary offerings. Most can justify them on the basis of poor results, but isn’t one of them, Legal & General, being a little greedy?

Who wants to do a rights issue? Not many companies, one would assume. Rights issues are typically seen as a last resort of managements desperate to repair balance sheets or in need of funding for acquisitions. A rights issue - the issue of new shares to existing shareholders - can raise a large amount of capital and allow shareholders to maintain their existing proportion of holdings.


But regardless of the stigma generally attached to rights issues, several insurers are lined up to make them. Most are doing so from a defensive, or rescue, position where they have little choice since they need the capital to shore up balance sheets but UK insurer Legal&General has done so by choice to fund organic growth.


       



You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of acces below.

SUBSCRIBE ONLINE TODAY

Unlimited access to Euromoney.com and Asiamoney.com

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£68.33 per month

Billed Annually

FREE 7 DAY TRIAL

Unlimited access to Euromoney.com and Asiamoney.com, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors

LOGIN NOW

Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree